Vir Biotechnology, Inc. — Director's Dealing 2021

Dec 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2021-11-29

Reporting Person: HANLY ANN M. (Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-29	Common Stock	P	11.52	$43.39	Acquired	11.52	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	30600	Direct

Footnotes

F1: The purchase was effectuated by a minor through a trading account registered in the name of the reporting person's spouse.

F2: Includes 600 shares of common stock acquired by the reporting person on November 30, 2021 pursuant to an employee stock purchase program.